Novo Nordisk shares plunge on outlook warning as Mounjaro rival races ahead

Wegovy and Ozempic maker Novo Nordisk forecast plunging sales and earnings in 2026, which saw the Danish drugmaker’s shares plummet by nearly a fifth.


1 M.
Sport
ID: -679306657137909020


Similar News expand_more


Sport
Sport
Sport
Sport
Politics
Sport
Sport
Economics
Sport
Sport
Sport
Entertainment
Sport
Sport
Sport
Sport
Sport
Sport
Sport
Economics
Sport
Sport
Sport
Sport
Military
Automotive
Sport
Sport
Sport
Politics
Sport
Politics
Sport
Sport
Sport
Sport
Military
Sport
Sport
Sport
Sport
Sport
Crime
Sport
Sport
Sport
Sport
Sport
Sport
Popular countries based on strong economic and political relations

Add Watch Country

arrow_drop_down